Linscomb & Williams, Inc. Novartis Ag Transaction History

Linscomb & Williams, Inc.

$2.01 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $259,665 - $317,991	3,437 New	3,437 $311,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $276,747 - $322,218	-3,437 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$80.11 - $90.62 $15,301 - $17,308	191 Added 5.88%	3,437 $301,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $159 - $176	-2 Reduced 0.06%	3,246 $284,000
Q3 2021 Nov 03, 2021	BUY	$81.78 - $95.14 $3,271 - $3,805	40 Added 1.25%	3,248 $266,000
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $15,087 - $16,664	-177 Reduced 5.23%	3,208 $293,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $7,682 - $9,059	-92 Reduced 2.65%	3,385 $289,000
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $3,591 - $4,343	46 Added 1.34%	3,477 $328,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $2,299 - $2,548	-28 Reduced 0.81%	3,431 $298,000
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $11,977 - $13,482	-148 Reduced 4.1%	3,459 $302,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $63,956 - $89,604	905 Added 33.49%	3,607 $297,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $1,096 - $1,239	13 Added 0.48%	2,702 $256,000
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $7,185 - $7,917	84 Added 3.22%	2,689 $234,000
Q2 2019 Aug 06, 2019	BUY	$75.4 - $92.8 $10,782 - $13,270	143 Added 5.81%	2,605 $238,000
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $12,383 - $14,324	-185 Reduced 6.99%	2,462 $212,000
Q2 2018 Aug 07, 2018	BUY	$64.91 - $73.36 $171,816 - $194,183	2,647 New	2,647 $200,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $174,496 - $208,607	-2,479 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $5,280 - $5,667	-73 Reduced 2.86%	2,479 $208,000
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $189,205 - $197,193	2,552	2,552 $219,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Account